nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRA—migraine	0.547	1	CbGaD
Sitaxentan—CYP2C19—Timolol—migraine	0.032	0.124	CbGbCtD
Sitaxentan—CYP2C19—Propranolol—migraine	0.0285	0.11	CbGbCtD
Sitaxentan—CYP2C19—Amitriptyline—migraine	0.0247	0.0953	CbGbCtD
Sitaxentan—CYP2C19—Valproic Acid—migraine	0.0225	0.0869	CbGbCtD
Sitaxentan—CYP2C9—Amitriptyline—migraine	0.0205	0.0792	CbGbCtD
Sitaxentan—CYP2C19—Topiramate—migraine	0.0203	0.0784	CbGbCtD
Sitaxentan—CYP2C19—Verapamil—migraine	0.0196	0.0756	CbGbCtD
Sitaxentan—CYP2C9—Valproic Acid—migraine	0.0187	0.0722	CbGbCtD
Sitaxentan—CYP2C9—Verapamil—migraine	0.0163	0.0629	CbGbCtD
Sitaxentan—CYP3A4—Propranolol—migraine	0.0138	0.0533	CbGbCtD
Sitaxentan—CYP3A4—Amitriptyline—migraine	0.0119	0.0461	CbGbCtD
Sitaxentan—CYP3A4—Valproic Acid—migraine	0.0109	0.042	CbGbCtD
Sitaxentan—CYP3A4—Topiramate—migraine	0.00981	0.0379	CbGbCtD
Sitaxentan—CYP3A4—Verapamil—migraine	0.00947	0.0366	CbGbCtD
Sitaxentan—EDNRB—Endothelin Pathways—RAMP1—migraine	0.00414	0.0704	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelin Pathways—CALCRL—migraine	0.00414	0.0704	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelin Pathways—RAMP1—migraine	0.00296	0.0504	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelin Pathways—CALCRL—migraine	0.00296	0.0504	CbGpPWpGaD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00178	0.0303	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelin Pathways—EDNRA—migraine	0.00165	0.028	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelin Pathways—CALCA—migraine	0.00159	0.027	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelin Pathways—CALCA—migraine	0.00113	0.0193	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—EDNRA—migraine	0.000982	0.0167	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—EDNRA—migraine	0.000863	0.0147	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HTR2B—migraine	0.000697	0.0119	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000624	0.0106	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00058	0.00987	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000539	0.00918	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—RAMP1—migraine	0.000521	0.00887	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CALCRL—migraine	0.000521	0.00887	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2B—migraine	0.000499	0.0085	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000497	0.00846	CbGpPWpGaD
Sitaxentan—EDNRB—Endothelins—FOS—migraine	0.000495	0.00843	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—HTR7—migraine	0.000471	0.00802	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000462	0.00786	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000446	0.0076	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—NPS—migraine	0.000431	0.00734	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—TAC1—migraine	0.000431	0.00734	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—TAC1—migraine	0.000425	0.00724	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—NPS—migraine	0.000425	0.00724	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HTR2C—migraine	0.000423	0.00719	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000415	0.00707	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—EDNRA—migraine	0.000411	0.007	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—EDNRA—migraine	0.000406	0.00691	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000386	0.00657	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000385	0.00656	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000385	0.00656	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR1D—migraine	0.000378	0.00644	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000378	0.00643	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—RAMP1—migraine	0.000373	0.00635	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CALCRL—migraine	0.000373	0.00635	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000368	0.00626	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000356	0.00605	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelins—FOS—migraine	0.000354	0.00603	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2B—migraine	0.000352	0.00599	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000351	0.00598	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000338	0.00576	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000331	0.00563	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—HTR2A—migraine	0.00033	0.00562	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000327	0.00556	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000318	0.00541	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—NPS—migraine	0.000308	0.00525	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—TAC1—migraine	0.000308	0.00525	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—TAC1—migraine	0.000304	0.00518	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—NPS—migraine	0.000304	0.00518	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2C—migraine	0.000302	0.00515	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000301	0.00513	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—RAMP1—migraine	0.000294	0.00501	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CALCRL—migraine	0.000294	0.00501	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00029	0.00493	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000286	0.00487	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000285	0.00486	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000285	0.00486	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00028	0.00476	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000276	0.0047	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000276	0.0047	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000272	0.00464	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR1D—migraine	0.000271	0.00461	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00027	0.00461	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CALCRL—migraine	0.000267	0.00455	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—RAMP1—migraine	0.000267	0.00455	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—HTR2A—migraine	0.000259	0.00441	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2B—migraine	0.000252	0.00429	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000251	0.00428	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000245	0.00417	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000242	0.00412	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000234	0.00398	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000232	0.00395	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR1B—migraine	0.000229	0.0039	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR1A—migraine	0.000221	0.00376	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—NPS—migraine	0.000217	0.0037	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—TAC1—migraine	0.000217	0.0037	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000215	0.00367	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR1D—migraine	0.000214	0.00364	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2C—migraine	0.000213	0.00363	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—RAMP1—migraine	0.000211	0.00359	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CALCRL—migraine	0.000211	0.00359	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000207	0.00353	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—EDNRA—migraine	0.000207	0.00353	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000205	0.00349	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000204	0.00348	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000204	0.00348	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.0002	0.00341	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.0002	0.00341	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CALCA—migraine	0.0002	0.0034	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2B—migraine	0.000199	0.00338	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR1D—migraine	0.000194	0.00331	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—RAMP1—migraine	0.000191	0.00326	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CALCRL—migraine	0.000191	0.00326	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR7—migraine	0.000187	0.00318	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—HTR2A—migraine	0.000186	0.00316	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2B—migraine	0.000181	0.00307	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000175	0.00299	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000172	0.00292	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000166	0.00283	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR1B—migraine	0.000164	0.00279	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR1A—migraine	0.000158	0.00269	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RAMP1—migraine	0.000158	0.00269	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CALCRL—migraine	0.000158	0.00269	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—NPS—migraine	0.000156	0.00265	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—TAC1—migraine	0.000156	0.00265	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR1D—migraine	0.000153	0.00261	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2C—migraine	0.000153	0.0026	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000143	0.00244	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CALCA—migraine	0.000143	0.00243	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2B—migraine	0.000142	0.00242	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR1D—migraine	0.000139	0.00237	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—HTR7—migraine	0.000134	0.00227	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—HTR2A—migraine	0.000131	0.00223	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR1B—migraine	0.00013	0.00221	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2B—migraine	0.000129	0.0022	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR1A—migraine	0.000125	0.00212	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000123	0.00209	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—TAC1—migraine	0.000123	0.00209	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—NPS—migraine	0.000123	0.00209	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2C—migraine	0.00012	0.00205	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR1B—migraine	0.000118	0.002	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—EDNRA—migraine	0.000117	0.00199	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR1D—migraine	0.000115	0.00195	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR1A—migraine	0.000113	0.00193	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CALCRL—migraine	0.000113	0.00192	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RAMP1—migraine	0.000113	0.00192	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CALCA—migraine	0.000113	0.00192	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TAC1—migraine	0.000112	0.0019	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—NPS—migraine	0.000112	0.0019	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2C—migraine	0.000109	0.00186	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2B—migraine	0.000107	0.00182	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EDNRA—migraine	0.000106	0.00181	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR7—migraine	0.000105	0.0018	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CALCA—migraine	0.000102	0.00174	CbGpPWpGaD
Sitaxentan—Visual impairment—Timolol—migraine	9.65e-05	0.000712	CcSEcCtD
Sitaxentan—Pain—Verapamil—migraine	9.64e-05	0.000711	CcSEcCtD
Sitaxentan—Constipation—Verapamil—migraine	9.64e-05	0.000711	CcSEcCtD
Sitaxentan—Tension—Valproic Acid—migraine	9.61e-05	0.000709	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—HTR7—migraine	9.58e-05	0.00163	CbGpPWpGaD
Sitaxentan—Vomiting—Amitriptyline—migraine	9.57e-05	0.000706	CcSEcCtD
Sitaxentan—Angina pectoris—Topiramate—migraine	9.55e-05	0.000704	CcSEcCtD
Sitaxentan—Nervousness—Valproic Acid—migraine	9.51e-05	0.000702	CcSEcCtD
Sitaxentan—Bradycardia—Gabapentin—migraine	9.5e-05	0.0007	CcSEcCtD
Sitaxentan—Rash—Amitriptyline—migraine	9.49e-05	0.0007	CcSEcCtD
Sitaxentan—Dermatitis—Amitriptyline—migraine	9.48e-05	0.000699	CcSEcCtD
Sitaxentan—Headache—Amitriptyline—migraine	9.43e-05	0.000695	CcSEcCtD
Sitaxentan—Bronchitis—Topiramate—migraine	9.43e-05	0.000695	CcSEcCtD
Sitaxentan—Muscle spasms—Valproic Acid—migraine	9.42e-05	0.000694	CcSEcCtD
Sitaxentan—Abdominal discomfort—Topiramate—migraine	9.4e-05	0.000693	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—LRP1—migraine	9.39e-05	0.0016	CbGpPWpGaD
Sitaxentan—Eye disorder—Timolol—migraine	9.36e-05	0.00069	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—HTR2A—migraine	9.36e-05	0.00159	CbGpPWpGaD
Sitaxentan—Rhinitis—Gabapentin—migraine	9.35e-05	0.00069	CcSEcCtD
Sitaxentan—Tinnitus—Timolol—migraine	9.34e-05	0.000689	CcSEcCtD
Sitaxentan—Haemorrhage—Gabapentin—migraine	9.33e-05	0.000688	CcSEcCtD
Sitaxentan—Hepatitis—Gabapentin—migraine	9.33e-05	0.000688	CcSEcCtD
Sitaxentan—Pancytopenia—Topiramate—migraine	9.31e-05	0.000687	CcSEcCtD
Sitaxentan—Cardiac disorder—Timolol—migraine	9.3e-05	0.000685	CcSEcCtD
Sitaxentan—Feeling abnormal—Verapamil—migraine	9.29e-05	0.000685	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR1B—migraine	9.27e-05	0.00158	CbGpPWpGaD
Sitaxentan—Urinary tract disorder—Gabapentin—migraine	9.21e-05	0.000679	CcSEcCtD
Sitaxentan—Oedema peripheral—Gabapentin—migraine	9.19e-05	0.000678	CcSEcCtD
Sitaxentan—Tremor—Valproic Acid—migraine	9.18e-05	0.000677	CcSEcCtD
Sitaxentan—Dysuria—Topiramate—migraine	9.17e-05	0.000676	CcSEcCtD
Sitaxentan—Urethral disorder—Gabapentin—migraine	9.14e-05	0.000674	CcSEcCtD
Sitaxentan—Ill-defined disorder—Valproic Acid—migraine	9.09e-05	0.00067	CcSEcCtD
Sitaxentan—Angiopathy—Timolol—migraine	9.09e-05	0.00067	CcSEcCtD
Sitaxentan—Pollakiuria—Topiramate—migraine	9.06e-05	0.000668	CcSEcCtD
Sitaxentan—Anaemia—Valproic Acid—migraine	9.05e-05	0.000668	CcSEcCtD
Sitaxentan—Immune system disorder—Timolol—migraine	9.05e-05	0.000667	CcSEcCtD
Sitaxentan—Hypersensitivity—Propranolol—migraine	9.03e-05	0.000666	CcSEcCtD
Sitaxentan—Mediastinal disorder—Timolol—migraine	9.03e-05	0.000666	CcSEcCtD
Sitaxentan—Agitation—Valproic Acid—migraine	9e-05	0.000664	CcSEcCtD
Sitaxentan—Visual impairment—Gabapentin—migraine	8.99e-05	0.000663	CcSEcCtD
Sitaxentan—Urticaria—Verapamil—migraine	8.96e-05	0.00066	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Topiramate—migraine	8.95e-05	0.00066	CcSEcCtD
Sitaxentan—Nausea—Amitriptyline—migraine	8.94e-05	0.000659	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR1A—migraine	8.92e-05	0.00152	CbGpPWpGaD
Sitaxentan—Weight decreased—Topiramate—migraine	8.87e-05	0.000654	CcSEcCtD
Sitaxentan—Alopecia—Timolol—migraine	8.85e-05	0.000653	CcSEcCtD
Sitaxentan—Hyperglycaemia—Topiramate—migraine	8.84e-05	0.000652	CcSEcCtD
Sitaxentan—Malaise—Valproic Acid—migraine	8.83e-05	0.000651	CcSEcCtD
Sitaxentan—Vertigo—Valproic Acid—migraine	8.8e-05	0.000649	CcSEcCtD
Sitaxentan—Asthenia—Propranolol—migraine	8.79e-05	0.000648	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—NPS—migraine	8.79e-05	0.0015	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—TAC1—migraine	8.79e-05	0.0015	CbGpPWpGaD
Sitaxentan—Mental disorder—Timolol—migraine	8.78e-05	0.000647	CcSEcCtD
Sitaxentan—Leukopenia—Valproic Acid—migraine	8.77e-05	0.000647	CcSEcCtD
Sitaxentan—Infestation NOS—Topiramate—migraine	8.74e-05	0.000645	CcSEcCtD
Sitaxentan—Infestation—Topiramate—migraine	8.74e-05	0.000645	CcSEcCtD
Sitaxentan—Malnutrition—Timolol—migraine	8.72e-05	0.000643	CcSEcCtD
Sitaxentan—Eye disorder—Gabapentin—migraine	8.72e-05	0.000643	CcSEcCtD
Sitaxentan—Tinnitus—Gabapentin—migraine	8.7e-05	0.000641	CcSEcCtD
Sitaxentan—Cardiac disorder—Gabapentin—migraine	8.66e-05	0.000638	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2C—migraine	8.62e-05	0.00147	CbGpPWpGaD
Sitaxentan—Renal failure—Topiramate—migraine	8.59e-05	0.000634	CcSEcCtD
Sitaxentan—Tension—Timolol—migraine	8.56e-05	0.000631	CcSEcCtD
Sitaxentan—Stomatitis—Topiramate—migraine	8.52e-05	0.000628	CcSEcCtD
Sitaxentan—Conjunctivitis—Topiramate—migraine	8.5e-05	0.000627	CcSEcCtD
Sitaxentan—Nervousness—Timolol—migraine	8.47e-05	0.000624	CcSEcCtD
Sitaxentan—Immune system disorder—Gabapentin—migraine	8.43e-05	0.000621	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR1B—migraine	8.42e-05	0.00143	CbGpPWpGaD
Sitaxentan—Mediastinal disorder—Gabapentin—migraine	8.41e-05	0.00062	CcSEcCtD
Sitaxentan—Diarrhoea—Propranolol—migraine	8.39e-05	0.000618	CcSEcCtD
Sitaxentan—Chest pain—Valproic Acid—migraine	8.34e-05	0.000615	CcSEcCtD
Sitaxentan—Haematuria—Topiramate—migraine	8.34e-05	0.000615	CcSEcCtD
Sitaxentan—Hypersensitivity—Verapamil—migraine	8.31e-05	0.000613	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	8.28e-05	0.000611	CcSEcCtD
Sitaxentan—Epistaxis—Topiramate—migraine	8.25e-05	0.000608	CcSEcCtD
Sitaxentan—Alopecia—Gabapentin—migraine	8.24e-05	0.000608	CcSEcCtD
Sitaxentan—Discomfort—Valproic Acid—migraine	8.24e-05	0.000608	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR1D—migraine	8.21e-05	0.0014	CbGpPWpGaD
Sitaxentan—Sinusitis—Topiramate—migraine	8.2e-05	0.000605	CcSEcCtD
Sitaxentan—Mental disorder—Gabapentin—migraine	8.17e-05	0.000603	CcSEcCtD
Sitaxentan—Dry mouth—Valproic Acid—migraine	8.16e-05	0.000601	CcSEcCtD
Sitaxentan—Malnutrition—Gabapentin—migraine	8.12e-05	0.000599	CcSEcCtD
Sitaxentan—Dizziness—Propranolol—migraine	8.11e-05	0.000598	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR1A—migraine	8.1e-05	0.00138	CbGpPWpGaD
Sitaxentan—Asthenia—Verapamil—migraine	8.09e-05	0.000596	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CALCA—migraine	8.07e-05	0.00137	CbGpPWpGaD
Sitaxentan—Confusional state—Valproic Acid—migraine	8.06e-05	0.000594	CcSEcCtD
Sitaxentan—Oedema—Valproic Acid—migraine	7.99e-05	0.000589	CcSEcCtD
Sitaxentan—Bradycardia—Topiramate—migraine	7.99e-05	0.000589	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—TAC1—migraine	7.98e-05	0.00136	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—NPS—migraine	7.98e-05	0.00136	CbGpPWpGaD
Sitaxentan—Tension—Gabapentin—migraine	7.97e-05	0.000588	CcSEcCtD
Sitaxentan—Infection—Valproic Acid—migraine	7.94e-05	0.000586	CcSEcCtD
Sitaxentan—Haemoglobin—Topiramate—migraine	7.89e-05	0.000582	CcSEcCtD
Sitaxentan—Nervousness—Gabapentin—migraine	7.89e-05	0.000582	CcSEcCtD
Sitaxentan—Rhinitis—Topiramate—migraine	7.87e-05	0.00058	CcSEcCtD
Sitaxentan—Hepatitis—Topiramate—migraine	7.85e-05	0.000579	CcSEcCtD
Sitaxentan—Haemorrhage—Topiramate—migraine	7.85e-05	0.000579	CcSEcCtD
Sitaxentan—Nervous system disorder—Valproic Acid—migraine	7.84e-05	0.000578	CcSEcCtD
Sitaxentan—Vertigo—Timolol—migraine	7.83e-05	0.000578	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2C—migraine	7.83e-05	0.00133	CbGpPWpGaD
Sitaxentan—Thrombocytopenia—Valproic Acid—migraine	7.83e-05	0.000577	CcSEcCtD
Sitaxentan—Muscle spasms—Gabapentin—migraine	7.81e-05	0.000576	CcSEcCtD
Sitaxentan—Tachycardia—Valproic Acid—migraine	7.8e-05	0.000575	CcSEcCtD
Sitaxentan—Vomiting—Propranolol—migraine	7.79e-05	0.000575	CcSEcCtD
Sitaxentan—Skin disorder—Valproic Acid—migraine	7.77e-05	0.000573	CcSEcCtD
Sitaxentan—Urinary tract disorder—Topiramate—migraine	7.75e-05	0.000571	CcSEcCtD
Sitaxentan—Oedema peripheral—Topiramate—migraine	7.73e-05	0.00057	CcSEcCtD
Sitaxentan—Rash—Propranolol—migraine	7.73e-05	0.00057	CcSEcCtD
Sitaxentan—Dermatitis—Propranolol—migraine	7.72e-05	0.000569	CcSEcCtD
Sitaxentan—Diarrhoea—Verapamil—migraine	7.71e-05	0.000569	CcSEcCtD
Sitaxentan—Urethral disorder—Topiramate—migraine	7.69e-05	0.000567	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR2B—migraine	7.63e-05	0.0013	CbGpPWpGaD
Sitaxentan—Anorexia—Valproic Acid—migraine	7.62e-05	0.000562	CcSEcCtD
Sitaxentan—Tremor—Gabapentin—migraine	7.61e-05	0.000561	CcSEcCtD
Sitaxentan—Visual impairment—Topiramate—migraine	7.56e-05	0.000558	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR7—migraine	7.55e-05	0.00129	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Gabapentin—migraine	7.53e-05	0.000556	CcSEcCtD
Sitaxentan—Anaemia—Gabapentin—migraine	7.51e-05	0.000553	CcSEcCtD
Sitaxentan—Hypotension—Valproic Acid—migraine	7.47e-05	0.000551	CcSEcCtD
Sitaxentan—Agitation—Gabapentin—migraine	7.46e-05	0.00055	CcSEcCtD
Sitaxentan—Dizziness—Verapamil—migraine	7.46e-05	0.00055	CcSEcCtD
Sitaxentan—Chest pain—Timolol—migraine	7.42e-05	0.000547	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—HTR2A—migraine	7.39e-05	0.00126	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	7.37e-05	0.000544	CcSEcCtD
Sitaxentan—Discomfort—Timolol—migraine	7.34e-05	0.000541	CcSEcCtD
Sitaxentan—Eye disorder—Topiramate—migraine	7.33e-05	0.000541	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CALCA—migraine	7.33e-05	0.00125	CbGpPWpGaD
Sitaxentan—Malaise—Gabapentin—migraine	7.32e-05	0.00054	CcSEcCtD
Sitaxentan—Tinnitus—Topiramate—migraine	7.32e-05	0.00054	CcSEcCtD
Sitaxentan—Vertigo—Gabapentin—migraine	7.3e-05	0.000538	CcSEcCtD
Sitaxentan—Flushing—Topiramate—migraine	7.28e-05	0.000537	CcSEcCtD
Sitaxentan—Cardiac disorder—Topiramate—migraine	7.28e-05	0.000537	CcSEcCtD
Sitaxentan—Nausea—Propranolol—migraine	7.28e-05	0.000537	CcSEcCtD
Sitaxentan—Leukopenia—Gabapentin—migraine	7.27e-05	0.000536	CcSEcCtD
Sitaxentan—Dry mouth—Timolol—migraine	7.26e-05	0.000535	CcSEcCtD
Sitaxentan—Insomnia—Valproic Acid—migraine	7.23e-05	0.000533	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH4—migraine	7.2e-05	0.00123	CbGpPWpGaD
Sitaxentan—Confusional state—Timolol—migraine	7.18e-05	0.000529	CcSEcCtD
Sitaxentan—Vomiting—Verapamil—migraine	7.17e-05	0.000529	CcSEcCtD
Sitaxentan—Angiopathy—Topiramate—migraine	7.12e-05	0.000525	CcSEcCtD
Sitaxentan—Oedema—Timolol—migraine	7.12e-05	0.000525	CcSEcCtD
Sitaxentan—Rash—Verapamil—migraine	7.11e-05	0.000524	CcSEcCtD
Sitaxentan—Somnolence—Valproic Acid—migraine	7.11e-05	0.000524	CcSEcCtD
Sitaxentan—Dermatitis—Verapamil—migraine	7.1e-05	0.000524	CcSEcCtD
Sitaxentan—Immune system disorder—Topiramate—migraine	7.09e-05	0.000523	CcSEcCtD
Sitaxentan—Mediastinal disorder—Topiramate—migraine	7.07e-05	0.000522	CcSEcCtD
Sitaxentan—Infection—Timolol—migraine	7.07e-05	0.000521	CcSEcCtD
Sitaxentan—Headache—Verapamil—migraine	7.06e-05	0.000521	CcSEcCtD
Sitaxentan—Dyspepsia—Valproic Acid—migraine	7.04e-05	0.000519	CcSEcCtD
Sitaxentan—Nervous system disorder—Timolol—migraine	6.98e-05	0.000515	CcSEcCtD
Sitaxentan—Decreased appetite—Valproic Acid—migraine	6.95e-05	0.000512	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HTR1B—migraine	6.95e-05	0.00118	CbGpPWpGaD
Sitaxentan—Alopecia—Topiramate—migraine	6.94e-05	0.000511	CcSEcCtD
Sitaxentan—Chest pain—Gabapentin—migraine	6.91e-05	0.00051	CcSEcCtD
Sitaxentan—Skin disorder—Timolol—migraine	6.91e-05	0.00051	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Valproic Acid—migraine	6.9e-05	0.000509	CcSEcCtD
Sitaxentan—Fatigue—Valproic Acid—migraine	6.89e-05	0.000508	CcSEcCtD
Sitaxentan—Mental disorder—Topiramate—migraine	6.88e-05	0.000507	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	6.87e-05	0.000506	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR7—migraine	6.86e-05	0.00117	CbGpPWpGaD
Sitaxentan—Pain—Valproic Acid—migraine	6.84e-05	0.000504	CcSEcCtD
Sitaxentan—Constipation—Valproic Acid—migraine	6.84e-05	0.000504	CcSEcCtD
Sitaxentan—Malnutrition—Topiramate—migraine	6.83e-05	0.000504	CcSEcCtD
Sitaxentan—Discomfort—Gabapentin—migraine	6.83e-05	0.000504	CcSEcCtD
Sitaxentan—Anorexia—Timolol—migraine	6.78e-05	0.0005	CcSEcCtD
Sitaxentan—Dry mouth—Gabapentin—migraine	6.76e-05	0.000499	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—LRP1—migraine	6.72e-05	0.00114	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—migraine	6.71e-05	0.00114	CbGpPWpGaD
Sitaxentan—Tension—Topiramate—migraine	6.7e-05	0.000494	CcSEcCtD
Sitaxentan—Nausea—Verapamil—migraine	6.7e-05	0.000494	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HTR1A—migraine	6.69e-05	0.00114	CbGpPWpGaD
Sitaxentan—Confusional state—Gabapentin—migraine	6.68e-05	0.000493	CcSEcCtD
Sitaxentan—Hypotension—Timolol—migraine	6.65e-05	0.00049	CcSEcCtD
Sitaxentan—Nervousness—Topiramate—migraine	6.64e-05	0.000489	CcSEcCtD
Sitaxentan—Oedema—Gabapentin—migraine	6.63e-05	0.000489	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—TAC1—migraine	6.59e-05	0.00112	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NPS—migraine	6.59e-05	0.00112	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PGR—migraine	6.59e-05	0.00112	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Valproic Acid—migraine	6.59e-05	0.000486	CcSEcCtD
Sitaxentan—Infection—Gabapentin—migraine	6.58e-05	0.000485	CcSEcCtD
Sitaxentan—Muscle spasms—Topiramate—migraine	6.57e-05	0.000484	CcSEcCtD
Sitaxentan—Nervous system disorder—Gabapentin—migraine	6.5e-05	0.000479	CcSEcCtD
Sitaxentan—Thrombocytopenia—Gabapentin—migraine	6.49e-05	0.000478	CcSEcCtD
Sitaxentan—Tachycardia—Gabapentin—migraine	6.47e-05	0.000477	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HTR2C—migraine	6.46e-05	0.0011	CbGpPWpGaD
Sitaxentan—Skin disorder—Gabapentin—migraine	6.44e-05	0.000475	CcSEcCtD
Sitaxentan—Insomnia—Timolol—migraine	6.44e-05	0.000475	CcSEcCtD
Sitaxentan—Tremor—Topiramate—migraine	6.4e-05	0.000472	CcSEcCtD
Sitaxentan—Urticaria—Valproic Acid—migraine	6.35e-05	0.000468	CcSEcCtD
Sitaxentan—Ill-defined disorder—Topiramate—migraine	6.34e-05	0.000467	CcSEcCtD
Sitaxentan—Somnolence—Timolol—migraine	6.33e-05	0.000467	CcSEcCtD
Sitaxentan—Body temperature increased—Valproic Acid—migraine	6.32e-05	0.000466	CcSEcCtD
Sitaxentan—Anorexia—Gabapentin—migraine	6.32e-05	0.000466	CcSEcCtD
Sitaxentan—Anaemia—Topiramate—migraine	6.31e-05	0.000466	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—EDNRA—migraine	6.28e-05	0.00107	CbGpPWpGaD
Sitaxentan—Agitation—Topiramate—migraine	6.28e-05	0.000463	CcSEcCtD
Sitaxentan—Dyspepsia—Timolol—migraine	6.26e-05	0.000462	CcSEcCtD
Sitaxentan—Hypotension—Gabapentin—migraine	6.19e-05	0.000457	CcSEcCtD
Sitaxentan—Decreased appetite—Timolol—migraine	6.19e-05	0.000456	CcSEcCtD
Sitaxentan—Malaise—Topiramate—migraine	6.16e-05	0.000454	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Timolol—migraine	6.14e-05	0.000453	CcSEcCtD
Sitaxentan—Vertigo—Topiramate—migraine	6.14e-05	0.000453	CcSEcCtD
Sitaxentan—Fatigue—Timolol—migraine	6.14e-05	0.000452	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH3—migraine	6.12e-05	0.00104	CbGpPWpGaD
Sitaxentan—Leukopenia—Topiramate—migraine	6.12e-05	0.000451	CcSEcCtD
Sitaxentan—Pain—Timolol—migraine	6.09e-05	0.000449	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CALCA—migraine	6.05e-05	0.00103	CbGpPWpGaD
Sitaxentan—Insomnia—Gabapentin—migraine	5.99e-05	0.000442	CcSEcCtD
Sitaxentan—Somnolence—Gabapentin—migraine	5.89e-05	0.000434	CcSEcCtD
Sitaxentan—Hypersensitivity—Valproic Acid—migraine	5.89e-05	0.000434	CcSEcCtD
Sitaxentan—Feeling abnormal—Timolol—migraine	5.86e-05	0.000432	CcSEcCtD
Sitaxentan—Dyspepsia—Gabapentin—migraine	5.83e-05	0.00043	CcSEcCtD
Sitaxentan—Chest pain—Topiramate—migraine	5.82e-05	0.000429	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	5.78e-05	0.000426	CcSEcCtD
Sitaxentan—Decreased appetite—Gabapentin—migraine	5.76e-05	0.000425	CcSEcCtD
Sitaxentan—Discomfort—Topiramate—migraine	5.75e-05	0.000424	CcSEcCtD
Sitaxentan—Asthenia—Valproic Acid—migraine	5.74e-05	0.000423	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Gabapentin—migraine	5.72e-05	0.000422	CcSEcCtD
Sitaxentan—Fatigue—Gabapentin—migraine	5.71e-05	0.000421	CcSEcCtD
Sitaxentan—Dry mouth—Topiramate—migraine	5.69e-05	0.000419	CcSEcCtD
Sitaxentan—Pain—Gabapentin—migraine	5.67e-05	0.000418	CcSEcCtD
Sitaxentan—Constipation—Gabapentin—migraine	5.67e-05	0.000418	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HTR7—migraine	5.66e-05	0.000963	CbGpPWpGaD
Sitaxentan—Urticaria—Timolol—migraine	5.65e-05	0.000417	CcSEcCtD
Sitaxentan—Body temperature increased—Timolol—migraine	5.63e-05	0.000415	CcSEcCtD
Sitaxentan—Confusional state—Topiramate—migraine	5.62e-05	0.000415	CcSEcCtD
Sitaxentan—Oedema—Topiramate—migraine	5.58e-05	0.000411	CcSEcCtD
Sitaxentan—Infection—Topiramate—migraine	5.54e-05	0.000408	CcSEcCtD
Sitaxentan—Diarrhoea—Valproic Acid—migraine	5.47e-05	0.000403	CcSEcCtD
Sitaxentan—Nervous system disorder—Topiramate—migraine	5.47e-05	0.000403	CcSEcCtD
Sitaxentan—Feeling abnormal—Gabapentin—migraine	5.46e-05	0.000403	CcSEcCtD
Sitaxentan—Thrombocytopenia—Topiramate—migraine	5.46e-05	0.000403	CcSEcCtD
Sitaxentan—Tachycardia—Topiramate—migraine	5.44e-05	0.000401	CcSEcCtD
Sitaxentan—Skin disorder—Topiramate—migraine	5.42e-05	0.000399	CcSEcCtD
Sitaxentan—Anorexia—Topiramate—migraine	5.31e-05	0.000392	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—migraine	5.29e-05	0.0009	CbGpPWpGaD
Sitaxentan—Dizziness—Valproic Acid—migraine	5.29e-05	0.00039	CcSEcCtD
Sitaxentan—Urticaria—Gabapentin—migraine	5.26e-05	0.000388	CcSEcCtD
Sitaxentan—Hypersensitivity—Timolol—migraine	5.24e-05	0.000387	CcSEcCtD
Sitaxentan—Body temperature increased—Gabapentin—migraine	5.24e-05	0.000386	CcSEcCtD
Sitaxentan—Hypotension—Topiramate—migraine	5.21e-05	0.000384	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH4—migraine	5.16e-05	0.000878	CbGpPWpGaD
Sitaxentan—Asthenia—Timolol—migraine	5.11e-05	0.000376	CcSEcCtD
Sitaxentan—Vomiting—Valproic Acid—migraine	5.08e-05	0.000375	CcSEcCtD
Sitaxentan—Insomnia—Topiramate—migraine	5.04e-05	0.000372	CcSEcCtD
Sitaxentan—Rash—Valproic Acid—migraine	5.04e-05	0.000372	CcSEcCtD
Sitaxentan—Dermatitis—Valproic Acid—migraine	5.04e-05	0.000371	CcSEcCtD
Sitaxentan—Headache—Valproic Acid—migraine	5.01e-05	0.000369	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR1B—migraine	4.97e-05	0.000847	CbGpPWpGaD
Sitaxentan—Somnolence—Topiramate—migraine	4.96e-05	0.000365	CcSEcCtD
Sitaxentan—Dyspepsia—Topiramate—migraine	4.91e-05	0.000362	CcSEcCtD
Sitaxentan—Hypersensitivity—Gabapentin—migraine	4.88e-05	0.00036	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—TGFBR2—migraine	4.87e-05	0.00083	CbGpPWpGaD
Sitaxentan—Diarrhoea—Timolol—migraine	4.87e-05	0.000359	CcSEcCtD
Sitaxentan—Decreased appetite—Topiramate—migraine	4.85e-05	0.000357	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Topiramate—migraine	4.81e-05	0.000355	CcSEcCtD
Sitaxentan—Fatigue—Topiramate—migraine	4.81e-05	0.000354	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—migraine	4.8e-05	0.000818	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR1A—migraine	4.79e-05	0.000815	CbGpPWpGaD
Sitaxentan—Pain—Topiramate—migraine	4.77e-05	0.000352	CcSEcCtD
Sitaxentan—Constipation—Topiramate—migraine	4.77e-05	0.000352	CcSEcCtD
Sitaxentan—Asthenia—Gabapentin—migraine	4.76e-05	0.000351	CcSEcCtD
Sitaxentan—Nausea—Valproic Acid—migraine	4.75e-05	0.00035	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PGR—migraine	4.72e-05	0.000803	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPS—migraine	4.72e-05	0.000803	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TAC1—migraine	4.72e-05	0.000803	CbGpPWpGaD
Sitaxentan—Dizziness—Timolol—migraine	4.71e-05	0.000347	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR2C—migraine	4.62e-05	0.000787	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Topiramate—migraine	4.59e-05	0.000339	CcSEcCtD
Sitaxentan—Diarrhoea—Gabapentin—migraine	4.53e-05	0.000334	CcSEcCtD
Sitaxentan—Vomiting—Timolol—migraine	4.53e-05	0.000334	CcSEcCtD
Sitaxentan—Rash—Timolol—migraine	4.49e-05	0.000331	CcSEcCtD
Sitaxentan—Dermatitis—Timolol—migraine	4.48e-05	0.000331	CcSEcCtD
Sitaxentan—Headache—Timolol—migraine	4.46e-05	0.000329	CcSEcCtD
Sitaxentan—Urticaria—Topiramate—migraine	4.43e-05	0.000327	CcSEcCtD
Sitaxentan—Body temperature increased—Topiramate—migraine	4.41e-05	0.000325	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH3—migraine	4.38e-05	0.000746	CbGpPWpGaD
Sitaxentan—Dizziness—Gabapentin—migraine	4.38e-05	0.000323	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CALCA—migraine	4.33e-05	0.000737	CbGpPWpGaD
Sitaxentan—Nausea—Timolol—migraine	4.23e-05	0.000312	CcSEcCtD
Sitaxentan—Vomiting—Gabapentin—migraine	4.21e-05	0.000311	CcSEcCtD
Sitaxentan—Rash—Gabapentin—migraine	4.18e-05	0.000308	CcSEcCtD
Sitaxentan—Dermatitis—Gabapentin—migraine	4.17e-05	0.000308	CcSEcCtD
Sitaxentan—Headache—Gabapentin—migraine	4.15e-05	0.000306	CcSEcCtD
Sitaxentan—Hypersensitivity—Topiramate—migraine	4.11e-05	0.000303	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR7—migraine	4.05e-05	0.00069	CbGpPWpGaD
Sitaxentan—Asthenia—Topiramate—migraine	4e-05	0.000295	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—migraine	3.96e-05	0.000675	CbGpPWpGaD
Sitaxentan—Nausea—Gabapentin—migraine	3.94e-05	0.00029	CcSEcCtD
Sitaxentan—Diarrhoea—Topiramate—migraine	3.81e-05	0.000281	CcSEcCtD
Sitaxentan—Dizziness—Topiramate—migraine	3.69e-05	0.000272	CcSEcCtD
Sitaxentan—Vomiting—Topiramate—migraine	3.55e-05	0.000261	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ESR1—migraine	3.52e-05	0.000599	CbGpPWpGaD
Sitaxentan—Rash—Topiramate—migraine	3.52e-05	0.000259	CcSEcCtD
Sitaxentan—Dermatitis—Topiramate—migraine	3.51e-05	0.000259	CcSEcCtD
Sitaxentan—Headache—Topiramate—migraine	3.49e-05	0.000258	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—TGFBR2—migraine	3.49e-05	0.000594	CbGpPWpGaD
Sitaxentan—Nausea—Topiramate—migraine	3.31e-05	0.000244	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—migraine	2.84e-05	0.000483	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ESR1—migraine	2.52e-05	0.000429	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CACNA1A—migraine	2.42e-05	0.000411	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CACNA1A—migraine	2.2e-05	0.000375	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CACNA1A—migraine	1.45e-05	0.000247	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—migraine	7.99e-06	0.000136	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—migraine	7.29e-06	0.000124	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—migraine	4.81e-06	8.18e-05	CbGpPWpGaD
